Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases

Melloni B., Monteil J., Vincent F., Bertin F., Gaillard S., Ducloux T., Verbeke S., Maubon A., Vandroux J-C., Bonnaud F.

Source: Eur Respir J 2004; 24 : 814-821

Journal Issue: November

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Melloni B., Monteil J., Vincent F., Bertin F., Gaillard S., Ducloux T., Verbeke S., Maubon A., Vandroux J-C., Bonnaud F.. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 2004; 24 : 814-821

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Interest of ¹⁸F-FDG dual-head gamma camera coincidence imaging in subjets exposed to asbestos Source: Eur Respir J 2003; 22: Suppl. 45, 185s Year: 2003
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Retrosternal and pleural "bridging" fibrosis mimicking malignancy in a patient exposed to asbestos Source: Eur Respir Rev 2009; 19: 158-160 Year: 2010
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Source: Eur Respir J 2001; 17: 802-820 Year: 2001
Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008
Positron emission tomography (PET) using ¹⁸F-fluorodeoxyglucose (¹⁸FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013
Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002
Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
Surveillance for patients with curative-intent surgical resection for NSCLC: CT scaning versus ¹⁸F-FDG dual-head gamma camera Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004
Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015
Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005